search

Tonix Pharmaceuticals Holding Corp (TNXP)

OverviewChartFinancialsStatisticsEarningsInsider transactionsETFsNews

News

Real-time news feed aggregating press releases, regulatory filings, and global media coverage for a single company, filterable by date range, relevance score, and sentiment classification. Each article is tagged with company-specific and overall market sentiment — allowing investors to separate fundamental catalysts from broader market noise and monitor how the narrative around a stock is evolving over time.

Relevance *
40
Tonix Pharmaceuticals (NASDAQ:TNXP) Downgraded by Wall Street Zen to Sell
Sep 26, 2026

Tonix Pharmaceuticals (NASDAQ:TNXP) Downgraded by Wall Street Zen to Sell

Wall Street Zen has downgraded Tonix Pharmaceuticals (NASDAQ:TNXP) from "Hold" to "Sell," despite the broader analyst consensus remaining "Buy" with a target price of $24.50. The company's shares opened at $9.86, near their 12-month low, and are trading below key moving averages. While Tonix Pharmaceuticals reported a quarterly loss, it exceeded revenue expectations, and its CEO recently purchased shares, indicating some insider confidence.
Company relevance
100.00%
Company sentiment
Bearish
Overall sentiment
Bearish